您好，欢迎来到试剂仪器网！ [登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 产品库 > NLX-204 hydrochloride
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
NLX-204 hydrochloride
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
NLX-204 hydrochloride图片
包装与价格：
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
NLX-204 (hydrochloride) 是一种具有口服活性、有效、高亲和力和选择性的5-HT1A 受体偏向激动剂 (pKi=10.19)。NLX-204 (hydrochloride) 对 α1 和 D2 受体的亲和力高于对其他脱靶受体的亲和力。NLX-204 (hydrochloride) 可用于抗抑郁的研究。
分子式C20H23Cl2F2N3O2
分子量446.32
溶解度DMSO : 100 mg/mL (224.05 mM; Need ultrasonic)
储存条件4°C, away from moisture
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

NLX-204 (hydrochloride) is an orally active, potent, highly affinity and selective 5-HT1A receptor-biased agonist (pKi=10.19). NLX-204 (hydrochloride) shows relatively higher affinity for α1 and D2 receptors than for other off-targets. NLX-204 (hydrochloride) can be used for the research of antidepressant[1].

NLX-204 (10 μM) (hydrochloride) shows substantial binding inhibition (higher than 50%) for adrenergic α1A and α2A and dopaminergic D2S receptors. NLX-204 (1 μM) (hydrochloride) exhibits much lower binding inhibition at D2 and α2A receptors but maintains a relatively high value for the α1Areceptor. NLX-204 (0.1~10 μM) (hydrochloride) has a low propensity for hERG channel blockade and suggests that the investigated series has a low risk with respect to hERG-related cardiac safety. NLX-204 (hydrochloride) also exhibits high microsomal stability. NLX-204 (hydrochloride) displays no P-gp inhibition (6.5% of inhibition at 10 μM) as well as negligible inhibition of CYP3A4 and CYP2D6 (23.2 and 15.9% at 10 μM, respectively). NLX-204 (hydrochloride) does not elicit flat body posture (FBP), a common side effect of the 5-HT1A receptor stimulation, suggesting that its preference for activation of 5-HT1A receptor-mediated ERK1/2 phosphorylation in vitro translates to preferential antidepressant effects rather than induction of "behavioral syndrome"[1].

NLX-204 (2.5 mg/kg; p.o.) (hydrochloride) is rapidly absorbed from the gastrointestinal tract (Tmax = 15 min), reaches relatively high serum concentrations and shows higher concentration than those in serum for all doses[1].NLX-204 (0.04~2.5 mg/kg; p.o.) (hydrochloride) shows that statistically significant elevation of pERK1/2 is observed at the two highest doses (2.5 and 0.63 mg/kg), but a tendency to increase pERK1/2 levels is also seen at lower doses[1].NLX-204 (hydrochloride) robustly and significantly increases rat PFC ERK1/2 phosphorylation in a time dependent manner[1].

[1]. Sniecikowska J, et al. Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity. J Med Chem. 2019;62(5):2750-2771.